Effect of omega-3 supplementation vs. placebo on blood lipid levels in patients with ischemic heart disease: a systematic review and meta-analysis
Nutrition, Metabolism and Cardiovascular Diseases · 2026-09 · 36 (9) · 104765
DOI: 10.1016/j.numecd.2026.104765 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-09. Verfasst von Ammar Yasser Negm und 5 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Port Said University, Port Said, Egypt. Electronic address: mar333734@gmail.com. Hauptthemen laut MEDLINE: Myocardial Ischemia, Dyslipidemias, Dietary Supplements, Lipids. Die Arbeit nennt 15 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND AIM Residual dyslipidemia persists in ischemic heart disease (IHD) patients despite statins. Omega-3 fatty acids may help, but their precise lipid effects and clinical integration need clarification. This meta-analysis aims to evaluate omega-3's impact on lipid profiles in IHD and contextualize findings within modern prevention strategies. METHODS AND RESULTS We systematically searched PubMed, Cochrane, Web of Science, and Scopus (1988-2024) for RCTs of omega-3 (1-4 g/day EPA + DHA) versus placebo in IHD adults. Ten RCTs (n = 633) were included. Risk of bias (RoB 2) and evidence certainty (GRADE) were assessed. Random-effects meta-analysis was performed. Omega-3 significantly reduced triglycerides (MD: -17.53 mg/dL, 95% CI: -30.64 to -4.41; p = 0.009) and LDL-C (MD: -9.43 mg/dL, 95% CI: -14.20 to -4.65; p = 0.0001). A trend favored total cholesterol reduction (MD: -6.03 mg/dL, p = 0.05). HDL-C increased post-sensitivity analysis (MD: 1.66 mg/dL, p = 0.03). Heterogeneity was low (I2 = 0-31%). Evidence certainty was moderate for TG and LDL-C outcomes. CONCLUSIONS Omega-3 supplementation significantly improves atherogenic lipids in IHD patients, supporting its adjunctive use. Implementation should prioritize high-dose EPA formulations and integrate with statin therapy within digitally-enhanced secondary prevention programs. PROSPERO REGISTRATION NUMBER CRD42025643552.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Medicine, Port Said University, Port Said, Egypt. Electronic address: mar333734@gmail.com.
- Faculty of Medicine, Ain Shams University, Cairo, Egypt.
- Faculty of Medicine, South Valley University, Qena, Egypt.
- Faculty of Medicine, Assiut University, Assiut, Egypt.
- Faculty of Medicine, Al-Azhar University, Damietta, Egypt.
- Public Health and Community Medicine Department, Faculty of Medicine, Port Said University, Port Said, Egypt.
Zitieren
APA
Negm, A. Y., Ashour, A. S., Mohamed, M. Y., Yehia, A., Youseif, A. L., & Farrag, N. S. (2026). Effect of omega-3 supplementation vs. placebo on blood lipid levels in patients with ischemic heart disease: a systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 36(9), 104765. https://doi.org/10.1016/j.numecd.2026.104765
Vancouver
Negm AY, Ashour AS, Mohamed MY, Yehia A, Youseif AL, Farrag NS. Effect of omega-3 supplementation vs. placebo on blood lipid levels in patients with ischemic heart disease: a systematic review and meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(9):104765. doi:10.1016/j.numecd.2026.104765
BibTeX
@article{Negm2026,
author = {Negm, Ammar Yasser and Ashour, Abdullah Samir and Mohamed, Mustafa Youssef and Yehia, Abdellrahman and Youseif, Ahmed L and Farrag, Nesrine Saad},
title = {Effect of omega-3 supplementation vs. placebo on blood lipid levels in patients with ischemic heart disease: a systematic review and meta-analysis},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
volume = {36},
number = {9},
pages = {104765},
doi = {10.1016/j.numecd.2026.104765}
}
EUVIMED